⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
REGN Stockholders Have Rights – If You Lost Money Investing in Regeneron Pharmaceuticals, Inc. Contact Robbins LLP for Information About Recovering Your Losses
globenewswire.com
REGN
Contact Levi & Korsinsky by September 14, 2026 to Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
Investors Urged to Contact Levi & Korsinsky For Information Before September 14, 2026 - Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
Shareholders of Regeneron Pharmaceuticals, Inc. (REGN): Protect Your Rights Before September 14, 2026 - Contact Levi & Korsinsky
accessnewswire.com
REGN
Pomerantz LLP Advises Shareholders of Class Action Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
$REGN Stock News: Regeneron Securities Class Action is Pending - Investors Are Notified to Protect Your Rights
accessnewswire.com
REGN
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman
prnewswire.com
REGN
REGN ALERT: Securities Fraud Class Action Launched Against Regeneron Pharmaceuticals, Inc. - September 14, 2026 Deadline
accessnewswire.com
REGN
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
REGN
Investor Alert: Deadline Approaching to Join Regeneron Pharmaceuticals, Inc. (REGN) Class Action - Contact Levi & Korsinsky
accessnewswire.com
REGN